Mirati Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Mirati Therapeutics, Inc. has filed 798 SEC EDGAR filings since 10 May 2013

SEC filing history

Showing 26-50 of 798 matching filings.

Per page
25
Current page
2
4

FORM 4

Filing date
23 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-189965

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-196487

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-204720

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-218239

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-233027

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-235765

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-257641

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-265112

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-266178

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-271879

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-274878

S-8 POS

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-257636

POSASR

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-191872

POS AM

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-207848

POS AM

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-191544

POS AM

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-35921

25-NSE filing

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Jan 2024
Reporting date
08 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .